FELEXIN 250 FOR ORAL SUSPENSION 250 mg/5 ml
Product details
Registration number: SIN09472P
Classification: Prescription Only
Active ingredients: CEFALEXIN MONOHYDRATE EQV CEFALEXIN
Strength: 5300mg/ 100ml
Dosage form: POWDER, FOR SUSPENSION
Route: ORAL
Registrant: GOLDPLUS UNIVERSAL PTE LTD
ATC code: J01DB01
HSA approval date: 18 August 1997
Manufacturer(s): REMEDICA LTD
Manufacturing country/countries: CYPRUS
What are the HSA registration number and classification for FELEXIN 250 FOR ORAL SUSPENSION 250 mg/5 ml?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN09472P
Classification: Prescription Only
What active ingredients and strength are recorded for FELEXIN 250 FOR ORAL SUSPENSION 250 mg/5 ml?
According to the HSA dataset updated 7 August 2026:
Active ingredients: CEFALEXIN MONOHYDRATE EQV CEFALEXIN
Strength: 5300mg/ 100ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for FELEXIN 250 FOR ORAL SUSPENSION 250 mg/5 ml?
According to the HSA dataset updated 7 August 2026:
Dosage form: POWDER, FOR SUSPENSION
Route: ORAL
Who is the recorded registrant for FELEXIN 250 FOR ORAL SUSPENSION 250 mg/5 ml?
According to the HSA dataset updated 7 August 2026:
Registrant: GOLDPLUS UNIVERSAL PTE LTD
Which manufacturers and countries are listed for FELEXIN 250 FOR ORAL SUSPENSION 250 mg/5 ml?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): REMEDICA LTD
Manufacturing country/countries: CYPRUS
Where can I look up FELEXIN 250 FOR ORAL SUSPENSION 250 mg/5 ml in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN09472P or the exact product name FELEXIN 250 FOR ORAL SUSPENSION 250 mg/5 ml. The general register link does not preselect this product.
What are the source dates for this FELEXIN 250 FOR ORAL SUSPENSION 250 mg/5 ml record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this FELEXIN 250 FOR ORAL SUSPENSION 250 mg/5 ml record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN09472P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)